| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:35 | Exclusive-US sends subpoenas in Warner-Paramount antitrust review as probe picks up steam | ||
| 17:35 | Fed's Paulson says Iran war increases risks to growth, inflation | ||
| 16:35 | Fed's Barkin says 'fog' again obscuring economic outlook | ||
| 16:35 | Unilever shareholders to get majority stake in potential McCormick food deal, sources say | ||
| 16:35 | Europe's aviation agency touts improving ties with FAA, Boeing | ||
| 16:35 | Chile's Codelco reports $4.85 billion pre-tax profit in 2025 | ||
| 16:35 | US consumer sentiment slips to a three-month low in March | ||
| 15:35 | Cruise operator Carnival cuts annual profit forecast on higher fuel costs | ||
| 15:35 | Wall St opens lower as Iran strike delays offers limited calm | ||
| 15:35 | Middle East conflict drives record trading at NYSE-parent ICE | ||
| 14:35 | Oaktree private credit fund to pay out 8.5% in redemption requests | ||
| 14:35 | Emerging economies' record debt spree slumps into a freeze as Iran war rocks markets | ||
| 13:35 | Bus maker Marcopolo looks to exports to offset Brazil market slowdown | ||
| 13:05 | SpaceX's listing stirs up social media hype, ticker bets | ||
| 12:05 | US equity funds rebound with strongest inflows in four months | ||
| 12:05 | US stock futures subdued as Iran strike delay offers limited relief | ||
| 11:35 | US jobs data to give economic view for war-gripped markets | ||
| 11:35 | Global equity funds see biggest inflows in 2-1/2 months on Iran de-escalation hopes | ||
| 11:05 | Pernod-Ricard shares pare losses as market digests merger talks | ||
| 11:05 | China launches two probes into US trade practices | ||
| 11:05 | Exclusive-Huawei's new AI chip finds favour with ByteDance, Alibaba which plan to place orders, sources say | ||
| 09:35 | Italian regulator launches probe into LVMH, Sephora for unfair commercial practices | ||
| 09:35 | With 'no place to hide' traders spend sleepless nights as Iran war roils markets | ||
| 08:35 | China boycotts top AI conference after ban on papers from US-sanctioned entities | ||
| 08:35 | Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion |